In Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography.
about
Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias.Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's caseAssociations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.What Would Dr. James Parkinson Think Today? Tau and Other Imaging Possibilities in Parkinson's Disease.MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([(18)F]-AV-1451) Binding.18F-AV-1451 in Parkinson's Disease with and without dementia and in Dementia with Lewy Bodies.
P2860
In Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
In Vivo cortical tau in Parkin ...... positron emission tomography.
@en
In Vivo cortical tau in Parkin ...... positron emission tomography.
@nl
type
label
In Vivo cortical tau in Parkin ...... positron emission tomography.
@en
In Vivo cortical tau in Parkin ...... positron emission tomography.
@nl
prefLabel
In Vivo cortical tau in Parkin ...... positron emission tomography.
@en
In Vivo cortical tau in Parkin ...... positron emission tomography.
@nl
P2093
P2860
P50
P356
P1433
P1476
In Vivo cortical tau in Parkin ...... 1 positron emission tomography
@en
P2093
Karen Østergaard
Karoline Knudsen
Peter Parbo
Rola Ismail
Tatyana D Fedorova
P2860
P304
P356
10.1002/MDS.26961
P407
P577
2017-03-03T00:00:00Z